121 related articles for article (PubMed ID: 34481947)
21. Adjuvanted
Perera DJ; Hassan AS; Jia Y; Ricciardi A; McCluskie MJ; Weeratna RD; Ndao M
Front Immunol; 2020; 11():605288. PubMed ID: 33304354
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of local immune response to Fasciola hepatica experimental infection in the liver and hepatic lymph nodes of goats immunized with Sm14 vaccine antigen.
Mendes RE; Zafra R; Pérez-Ecija RA; Buffoni L; Martínez-Moreno A; Tendler M; Pérez J
Mem Inst Oswaldo Cruz; 2010 Aug; 105(5):698-705. PubMed ID: 20835620
[TBL] [Abstract][Full Text] [Related]
23. Preliminary analysis of Sm14 in distinct fractions of Schistosoma mansoni adult worm extract.
Thaumaturgo N; Vilar MM; Diogo CM; Edelenyi R; Tendler M
Mem Inst Oswaldo Cruz; 2001; 96 Suppl():79-83. PubMed ID: 11586430
[TBL] [Abstract][Full Text] [Related]
24.
Morais SB; Figueiredo BC; Assis NRG; Homan J; Mambelli FS; Bicalho RM; Souza C; Martins VP; Pinheiro CS; Oliveira SC
Front Immunol; 2018; 9():1762. PubMed ID: 30105029
[TBL] [Abstract][Full Text] [Related]
25. Identification of immunodominant epitopes of Schistosoma mansoni vaccine candidate antigens using human T cells.
Fonseca CT; Cunha-Neto E; Kalil J; Jesus AR; Correa-Oliveira R; Carvalho EM; Oliveira SC
Mem Inst Oswaldo Cruz; 2004; 99(5 Suppl 1):63-6. PubMed ID: 15486637
[TBL] [Abstract][Full Text] [Related]
26. Oral immunization with Salmonella harboring a Sm14-based DNA vaccine does not protect mice against Schistosoma mansoni infection.
Pacheco LG; Mati VL; Castro TL; Dorella FA; Oliveira SC; Miyoshi A; de Melo AL; Azevedo V
Parasitol Int; 2008 Dec; 57(4):506-8. PubMed ID: 18538627
[TBL] [Abstract][Full Text] [Related]
27. Human IgG1 and IgG3 recognition of Schistosoma mansoni 14kDa fatty acid-binding recombinant protein.
Brito CF; Fonseca CT; Goes AM; Azevedo V; Simpson AJ; Oliveira SC
Parasite Immunol; 2000 Jan; 22(1):41-8. PubMed ID: 10744504
[TBL] [Abstract][Full Text] [Related]
28. A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP-2 and Sm29 was able to induce protection against infection in mice.
Pinheiro CS; Ribeiro AP; Cardoso FC; Martins VP; Figueiredo BC; Assis NR; Morais SB; Caliari MV; Loukas A; Oliveira SC
Parasite Immunol; 2014 Jul; 36(7):303-12. PubMed ID: 24749785
[TBL] [Abstract][Full Text] [Related]
29. Vaccination against Schistosoma mansoni infection using 74 kDa Schistosoma protein antigen.
Attallah AM; Attia H; Ismail H; Yones E; El-Nashar EM; Abd El-Kader K; Tabll A; Saad A; Sultan A
Vaccine; 1999 Jul; 17(22):2786-91. PubMed ID: 10438048
[TBL] [Abstract][Full Text] [Related]
30. Oral administration of a live Aro attenuated Salmonella vaccine strain expressing 14-kDa Schistosoma mansoni fatty acid-binding protein induced partial protection against experimental schistosomiasis.
Pacheco LG; Zucconi E; Mati VL; Garcia RM; Miyoshi A; Oliveira SC; de Melo AL; Azevedo V
Acta Trop; 2005 Aug; 95(2):132-42. PubMed ID: 15993833
[TBL] [Abstract][Full Text] [Related]
31. Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems.
Vicente B; López-Abán J; Rojas-Caraballo J; del Olmo E; Fernández-Soto P; Muro A
Parasit Vectors; 2016 Apr; 9():216. PubMed ID: 27090442
[TBL] [Abstract][Full Text] [Related]
32. DNA vaccination using recombinant Schistosoma mansoni fatty acid binding protein (smFABP) gene.
Aly I; ELnain G; Hamad RS; Kilany M; Ghramh HA; Alshehri A; Dajem SM; Ibrahim EH
Exp Parasitol; 2018 Nov; 194():53-59. PubMed ID: 30266572
[TBL] [Abstract][Full Text] [Related]
33. The Schistosoma mansoni cyclophilin A epitope 107-121 induces a protective immune response against schistosomiasis.
de Melo TT; Mendes MM; Alves CC; Carvalho GB; Fernandes VC; Pimenta DLF; de Moraes Mourão M; Gai F; Kalli M; Coelho A; de Azambuja Ribeiro RIM; Falcone FH; Pereira RADS; Fonseca CT
Mol Immunol; 2019 Jul; 111():172-181. PubMed ID: 31063938
[TBL] [Abstract][Full Text] [Related]
34. Innate immunogenicity and in vitro protective potential of Schistosoma mansoni lung schistosomula excretory--secretory candidate vaccine antigens.
El Ridi R; Tallima H; Mahana N; Dalton JP
Microbes Infect; 2010 Sep; 12(10):700-9. PubMed ID: 20452455
[TBL] [Abstract][Full Text] [Related]
35. Vaccination against Fasciola hepatica infection using a Schistosoma mansoni defined recombinant antigen, Sm14.
Almeida MS; Torloni H; Lee-Ho P; Vilar MM; Thaumaturgo N; Simpson AJ; Tendler M
Parasite Immunol; 2003 Mar; 25(3):135-7. PubMed ID: 12911521
[TBL] [Abstract][Full Text] [Related]
36. Immunization with rP22 induces protective immunity against Schistosoma mansoni: effects on granuloma down-modulation and cytokine production.
Rezende CM; Silva MR; Santos IG; Silva GA; Gomes DA; Goes AM
Immunol Lett; 2011 Dec; 141(1):123-33. PubMed ID: 21945176
[TBL] [Abstract][Full Text] [Related]
37. Process development for production and purification of the Schistosoma mansoni Sm14 antigen.
Damasceno L; Ritter G; Batt CA
Protein Expr Purif; 2017 Jun; 134():72-81. PubMed ID: 28389350
[TBL] [Abstract][Full Text] [Related]
38. A Strong Humoral Immune Response Induced by a Vaccine Formulation Containing rSm29 Adsorbed to Alum Is Associated With Protection Against
Alves CC; Araujo N; Bernardes WPOS; Mendes MM; Oliveira SC; Fonseca CT
Front Immunol; 2018; 9():2488. PubMed ID: 30450095
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the use of C-terminal part of the Schistosoma mansoni 200kDa tegumental protein in schistosomiasis diagnosis and vaccine formulation.
Carvalho GB; Pacífico LG; Pimenta DL; Siqueira LM; Teixeira-Carvalho A; Coelho PM; Pinheiro Cda S; Fujiwara RT; Oliveira SC; Fonseca CT
Exp Parasitol; 2014 Apr; 139():24-32. PubMed ID: 24560833
[TBL] [Abstract][Full Text] [Related]
40. Papain-Based Vaccination Modulates Schistosoma mansoni Infection-Induced Cytokine Signals.
Abdel Aziz N; Tallima H; Hafez EA; El Ridi R
Scand J Immunol; 2016 Feb; 83(2):128-38. PubMed ID: 26603950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
